or Try an Advanced Search...

    Technical Analysis for TNYA - Tenaya Therapeutics, Inc.

    Grade Last Price % Change Price Change
    D 3.37 8.71% 0.27
    TNYA closed up 8.71 percent on Monday, July 1, 2024, on 1.44 times normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical TNYA trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    MACD Bullish Signal Line Cross Bullish 0.00%
    Wide Bands Range Expansion 0.00%
    Up 3 Days in a Row Strength 0.00%
    Pocket Pivot Bullish Swing Setup 8.71%
    Volume Surge Other 8.71%
    Wide Bands Range Expansion 8.71%
    Oversold Stochastic Weakness 8.71%
    Slingshot Bearish Bearish Swing Setup 14.63%
    Pocket Pivot Bullish Swing Setup 14.63%
    Older End-of-Day Signals for TNYA ...

       Recent Intraday Alerts

    Alert Time
    Up 1 ATR about 8 hours ago
    Up 5% about 9 hours ago
    60 Minute Opening Range Breakout about 9 hours ago
    1.5x Volume Pace about 10 hours ago
    Rose Above Previous Day's High about 10 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    TNYA Chart by TradingView
    Basic chart:

    Profile

    Tenaya Therapeutics, Inc. develops therapeutics for heart failure. It offers cellular regeneration platform, that enables in vivo reprogramming of cardiac fibroblasts into cardio myocytes by delivering proprietary transcription factors; gene therapy platform, that enables the targeted delivery of a payload to cardiac fibroblasts; and precision medicine platform, which provides personalized medicine approach to treat heart disease. The company was incorporated in 2016 and is based in South San Francisco, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Life Sciences Biology Gene Therapy Heart Failure Biomarkers Heart Disease Personalized Medicine Chemical Pathology Induced Stem Cells

    Is TNYA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 27 Tenaya Therapeutics Announces Research Leadership Updates
    Jun 18 Tenaya Therapeutics to Participate at the TD Cowen Genetic Medicines & RNA Summit
    Jun 10 William Blair starts Tenaya at outperform, cites upcoming data
    May 25 We're Keeping An Eye On Tenaya Therapeutics' (NASDAQ:TNYA) Cash Burn Rate
    May 15 Novo Holdings buys stake in life sciences tools company; BioMarin lays off 170
    May 15 Tenaya Therapeutics GAAP EPS of -$0.40 beats by $0.02
    May 14 Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
    May 12 13 Penny Stocks with Insider Buying in 2024
    May 2 Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual Meeting
    Apr 14 Institutions own 33% of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) shares but private equity firms control 44% of the company
    See more TNYA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 7.01
    52 Week Low 1.66
    Average Volume 363,170
    200-Day Moving Average 3.63
    50-Day Moving Average 3.99
    20-Day Moving Average 3.39
    10-Day Moving Average 3.08
    Average True Range 0.26
    RSI (14) 45.95
    ADX 23.17
    +DI 25.18
    -DI 30.31
    Chandelier Exit (Long, 3 ATRs) 3.52
    Chandelier Exit (Short, 3 ATRs) 3.35
    Upper Bollinger Bands 4.10
    Lower Bollinger Band 2.69
    Percent B (%b) 0.48
    BandWidth 41.43
    MACD Line -0.30
    MACD Signal Line -0.31
    MACD Histogram 0.0101
    Fundamentals Value
    Market Cap 229.53 Million
    Num Shares 68.1 Million
    EPS -1.86
    Price-to-Earnings (P/E) Ratio -1.81
    Price-to-Sales 0.00
    Price-to-Book 2.12
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.85
    Resistance 3 (R3) 3.81 3.61 3.77
    Resistance 2 (R2) 3.61 3.49 3.63 3.74
    Resistance 1 (R1) 3.49 3.41 3.55 3.53 3.72
    Pivot Point 3.29 3.29 3.32 3.31 3.29
    Support 1 (S1) 3.17 3.17 3.23 3.21 3.02
    Support 2 (S2) 2.97 3.09 2.99 3.00
    Support 3 (S3) 2.85 2.97 2.97
    Support 4 (S4) 2.89